Elan D Louis Selected Research

Tremor (Tremors)

1/2021	Primidone Intolerance in Essential tremor: Is it More than Just Age?
1/2020	Meat Consumption and Meat Cooking Practices in Essential Tremor: A Population-Based Study in the Faroe Islands.
1/2020	Blood Harmane (1-Methyl-9H-Pyrido[3,4-b]indole) and Mercury in Essential Tremor: A Population-Based, Environmental Epidemiology Study in the Faroe Islands.
1/2020	Cerebellar oscillations driven by synaptic pruning deficits of cerebellar climbing fibers contribute to tremor pathophysiology.
12/2019	Current Opinions and Consensus for Studying Tremor in Animal Models.
8/2019	Tremor.
11/2018	Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome.
1/2018	Caffeine Consumption in First-Degree Relatives of Essential Tremor Cases: Evidence of Dietary Modification Before Disease Onset.
1/2018	Self-report depressive symptoms are dissociated from tremor severity in essential tremor.
11/2017	Mercury-induced motor and sensory neurotoxicity: systematic review of workers currently exposed to mercury vapor.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elan D Louis Research Topics

Disease

53	Essential Tremor (Essential Tremors) 06/2022 - 11/2002
44	Tremor (Tremors) 01/2021 - 03/2004
23	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2005
8	Dementia (Dementias) 01/2015 - 07/2003
6	Dystonia (Limb Dystonia) 07/2017 - 12/2004
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2005
5	Cognitive Dysfunction 06/2022 - 08/2010
4	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 05/2006
3	Movement Disorders (Movement Disorder) 01/2022 - 01/2008
2	Cerebellar Ataxia (Dysmetria) 04/2022 - 01/2016
2	Epilepsy (Aura) 01/2021 - 05/2002
2	Tauopathies 01/2021 - 06/2014
2	Ataxia (Dyssynergia) 08/2020 - 07/2017
2	Parkinsonian Disorders (Parkinsonism) 01/2019 - 01/2018
2	Huntington Disease (Huntington's Disease) 07/2017 - 05/2006
2	Craniocerebral Trauma (Head Injury) 01/2015 - 11/2006
2	Gaucher Disease (Gaucher's Disease) 02/2014 - 01/2005
2	Nervous System Diseases (Neurological Disorders) 01/2011 - 01/2010
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Infections 08/2020
1	Cytokine Release Syndrome 08/2020
1	Disease Progression 03/2019
1	Abnormal Reflex (Hyperreflexia) 11/2017
1	Hyperkinesis 07/2017
1	Myoclonus (Nocturnal Myoclonus) 07/2017
1	Secondary Parkinson Disease (Secondary Parkinsonism) 07/2017
1	Restless Legs Syndrome (Restless Legs) 11/2016
1	Apnea 11/2016
1	Multiple System Atrophy 01/2016
1	Cerebellar Diseases (Cerebellar Syndrome) 01/2016
1	Motor Disorders 10/2015
1	Fragile X Tremor Ataxia Syndrome 05/2013

Drug/Important Bio-Agent (IBA)

16	harman (harmane)IBA 01/2020 - 08/2007
14	NeurotoxinsIBA 01/2020 - 05/2007
11	indoleIBA 01/2020 - 01/2008
6	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2010
6	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 09/2005
6	Pharmaceutical PreparationsIBA 08/2019 - 01/2007
4	Caffeine (No Doz)FDA LinkGeneric 01/2018 - 07/2003
4	Glucosylceramidase (Glucocerebrosidase)IBA 02/2014 - 01/2005
4	Levetiracetam (Keppra)FDA LinkGeneric 11/2005 - 05/2002
3	ElementsIBA 06/2022 - 03/2010
3	Ethanol (Ethyl Alcohol)IBA 12/2014 - 05/2004
3	Biological ProductsIBA 06/2014 - 07/2006
3	AlkaloidsIBA 03/2011 - 09/2010
3	Leucine (L-Leucine)FDA Link 10/2010 - 02/2010
2	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2012
2	tau Proteins (tau Protein)IBA 01/2021 - 06/2014
2	Primidone (Sertan)FDA LinkGeneric 01/2021 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2014
2	MercuryIBA 01/2020 - 11/2017
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 03/2019 - 01/2018
2	N-acetylaspartate (N-acetyl aspartate)IBA 01/2017 - 08/2007
2	Antidepressive Agents (Antidepressants)IBA 11/2016 - 01/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 01/2010
2	PesticidesIBA 12/2015 - 07/2006
2	SynucleinsIBA 12/2011 - 03/2011
2	Carbolines (Beta-Carbolines)IBA 03/2011 - 12/2010
2	Coffee FDA Link 01/2011 - 05/2004
2	Thromboplastin (Tissue Factor)IBA 01/2009 - 01/2005
2	Fibrinogen (Factor I)FDA Link 01/2009 - 01/2005
2	Prothrombin (Factor II)IBA 01/2009 - 01/2005
2	Protons (Proton)IBA 08/2007 - 11/2002
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	propylene diquat (PDQ(+))IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	ParaffinIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2020
1	glutamate receptor delta 2IBA 01/2020
1	ioflupaneIBA 03/2019
1	HarmalineIBA 01/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2016
1	BenzodiazepinesIBA 11/2016
1	Excitatory Amino AcidsIBA 11/2016
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2016
1	EnzymesIBA 01/2016
1	coenzyme Q10 (CoQ10)IBA 01/2016
1	InsecticidesIBA 12/2015
1	Chlorpyrifos (Lorsban)IBA 12/2015
1	OrganophosphatesIBA 12/2015
1	Aminolevulinic Acid (Levulan)FDA Link 05/2015
1	Oxidoreductases (Dehydrogenase)IBA 05/2015
1	ORALIT (ORS)IBA 01/2015
1	Vesicular Glutamate Transport ProteinsIBA 12/2014
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 11/2014
1	Glutamic Acid (Glutamate)FDA Link 11/2014
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2014
1	dimemorfan (AT 17)IBA 01/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014
1	Calbindin 1IBA 10/2013
1	UbiquitinIBA 05/2013

Therapy/Procedure

5	Deep Brain Stimulation 07/2016 - 01/2011
4	Therapeutics 12/2019 - 05/2006
3	Activities of Daily Living (ADL) 01/2019 - 02/2010
2	Diet Therapy (Therapy, Diet) 01/2018 - 05/2004
1	Neurofeedback 01/2018
1	Occupational Therapy (Therapy, Occupational) 01/2015